DNA encoding canine von Willebrand factor and methods of use

• US 6,410,237 B1
• Filed: 11/02/1999
• Issued: 06/25/2002
• Est. Priority Date: 07/18/1997
• Status: Expired due to Term

• Current Assignee: The Board of Trustees of Michigan State University (Michigan State University), Board of Regents of the University of Michigan (University of Michigan)
• Original Assignee: The Board of Trustees of Michigan State University (Michigan State University), Board of Regents of the University of Michigan (University of Michigan)
• Inventors: Brewer, George J., Venta, Patrick J., Yuzbasiyan-Gurkan, Vilma, Schall, William D.
• Primary Examiner(s): Zitomer, Stephanie
• Assistant Examiner(s): Tung, Joyce
• Application Number:
  US09/432,451
• Time in Patent Office: 966 Days
• Field of Search: 536/22.1, 536/23.5, 536/24.31, 536/24.33, 435/325, 435/252.3, 435/6, 435/91.1, 435/91.2
• US Class Current: 435/6.11
• CPC Class Codes: C07K 14/755 Factors VIII , e.g. factor VIII C (AHF), factor VIII Ag (VWF)
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2600/124 Animal traits, i.e. production traits, including athletic performance or the like
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers

Abstract

The complete sequence of the canine von Willebrand Factor cDNA and deduced amino acid sequence is provided. The mutation which causes von Willebrand'"'"'s Disease in Scottish Terriers, a single base deletion in exon 4, has also been determined. Methods for detecting carriers of the defective vWF gene are also provided.

Claims

1. An isolated nucleic acid comprising a nucleotide sequence encoding the polypeptide of SEQ ID NO. 2, having a mutation at codon 85.

2. The isolated nucleic acid of claim 1, wherein the mutation is a deletion.

3. A vector comprising the nucleic acid of claim 1.

4. A vector comprising the nucleic acid of claim 2.

5. A cell comprising the vector of claim 3.

6. A cell comprising the vector of claim 4.

7. The isolated nucleic acid of claim 1, wherein the nucleotide sequence is capable of hybridizing under high stringency conditions to the complement of SEQ ID NO. 1 having a base deletion at codon 85.

8. A vector comprising the nucleic acid of claim 7.

9. A cell comprising the vector of claim 8.

10. A method of detecting a canine von Willebrand Factor gene in a sample comprising the steps of:

a) contacting the sample with an oligonucleotide comprising contiguous nucleotides of the nucleic acid sequence of SEQ ID NO. 1 having a base deletion at codon 85, and capable of specifically hybridizing with the canine von Willebrand Factor gene, under conditions favorable for hybridization of the oligonucleotide to any complementary sequences of nucleic acid in the sample; and

b) detecting hybridization, thereby detecting a canine von Willebrand Factor gene.

11. The method of claim 10, further comprising the step of:

c) quantifying hybridization of the oligonucleotide to complementary sequence.

12. A method of detecting a canine von Willebrand Factor gene in a sample comprising the steps of:

a) contacting the sample with an oligonucleotide comprising contiguous nucleotides of the nucleic acid sequence that is complementary to the sequence of SEQ ID NO. 1 having a base deletion at codon 85, and capable of specifically hybridizing to the complementary nucleotide sequence, under conditions favorable for hybridization of the oligonucleotide to any complementary sequences of nucleic acid in the sample; and

b) detecting hybridization, thereby detecting a canine von Willebrand Factor gene.

13. The method of claim 12, further comprising the step of:

c) quantifying ybidization of the oligonucleotide to complementary sequences.

14. An assay kit for screening for a canine von Willebrand Factor gene comprising:

a) an oligonucleotide comprising contiguous nucleotides from the nucleic acid sequence that is complementary to the sequence of SEQ ID NO. 1 having a base deletion at codon 85, and capable of specifically hybridizing to the complementary nucleotide sequence; and

b) reagents for hybridization of the oligonucleotide to a complementary nucleic acid sequence.

15. An oligonucleotide probe capable of detecting a mutation associated with canine von Willebrand'"'"'s disease, wherein the mutation is a base deletion at codon 85 of the canine von Willebrand Factor gene.